NDC 68071-3892-01 - Telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3892
- Requested NDC
- 68071-3892-01
- Package NDCs from labels
- 68071-3892-1, 68071-3892-01
- Manufacturer
- NuCare Pharmaceuticals, Inc.
- Effective date
- 2025-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan - NuCare Pharmaceuticals, Inc. | NuCare Pharmaceuticals, Inc. | 2025-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3892-1 | Telmisartan | 100 in 1 BOTTLE | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | NorthStar RxLLC | 9c22a318-d1f2-4788-9331-66fed71ebf38 | 2025-12-06 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | bf8e95fa-d181-4b46-8609-497e14a73dc1 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
| Telmisartan | TELMISARTAN | NuCare Pharmaceuticals, Inc. | 3f021f06-99df-48d1-e063-6394a90a8d0f | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | ANDA207882 68071-3892-1 68071-3892 68071389201 205305 3f021f0f-b705-16c1-e063-6294a90aacef 3f021f06-99df-48d1-e063-6394a90a8d0f U5SYW473RQ |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| telmisartan and hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 0c1bd0f4-034e-486c-ae46-2855c8c9ebda | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 47c8eee0-f0b7-4bd8-97e9-0029aa1b37db | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| telmisartan | TELMISARTAN | PD-Rx Pharmaceuticals, Inc. | 56a72ddf-c2a2-45ce-91b1-1fcfbff52c10 | 2025-05-01 | Boxed warning, Warnings, Adverse reactions | 282755 U5SYW473RQ |
| telmisartan | TELMISARTAN | Bryant Ranch Prepack | 32489e86-0432-4d74-92f6-15e7450f52fa | 2025-04-29 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| telmisartan | TELMISARTAN | Bryant Ranch Prepack | 44e810d4-cf04-41d3-bdf8-0681210a669f | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
| telmisartan | TELMISARTAN | Ascend Laboratories, LLC | 29bddc43-2809-4e1f-ae35-2865e15e9bb6 | 2025-03-29 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Jubilant Cadista Pharmacuticals Inc. | e1a907a7-fad9-a860-8639-4c6136c85734 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Micardis HCT | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | b078dae2-664d-4144-847a-3b9d9b557402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | e2deff49-b75e-4aaa-8114-d5ea1e3a94a5 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 282755 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | b4ae8694-2af4-4acb-8634-b40c1cb6fb41 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.